Literature DB >> 11689590

Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.

S Nishimura, T Sato, H Ueda, K Ueda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11689590     DOI： 10.1200/JCO.2001.19.21.4182

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.

Authors:  Sofia Theodoropoulou; Paraskevi E Kolovou; Yuki Morizane; Maki Kayama; Fotini Nicolaou; Joan W Miller; Evangelos Gragoudas; Bruce R Ksander; Demetrios G Vavvas
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

Review 2.  Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Authors:  Eleanor M Pritchard; Michael A Dyer; R Kiplin Guy
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

3.  Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.

Authors:  Christophe Antczak; Carolyn Kloepping; Constantin Radu; Thorsten Genski; Lutz Müller-Kuhrt; Karsten Siems; Elisa de Stanchina; David H Abramson; Hakim Djaballah
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

4.  Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience.

Authors:  Amani Alkofide; Mouhab Ayas; Yasser Khafagah; Ashraf Rawashde; Mohamed Anas; Mary Barria; Khawar Siddiqui; Saleh Almesfer; Hind Alkatan
Journal:  Saudi J Ophthalmol       Date:  2013-07-19

5.  The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.

Authors:  Katarzyna Brodowska; Ahmad Al-Moujahed; Anna Marmalidou; Melissa Meyer Zu Horste; Joanna Cichy; Joan W Miller; Evangelos Gragoudas; Demetrios G Vavvas
Journal:  Exp Eye Res       Date:  2014-05-15       Impact factor: 3.467

6.  Magnetic Hyperthermia in Y79 Retinoblastoma and ARPE-19 Retinal Epithelial Cells: Tumor Selective Apoptotic Activity of Iron Oxide Nanoparticle.

Authors:  Hakan Demirci; Naziha Slimani; Mercy Pawar; Ronald E Kumon; Prem Vaishnava; Cagri G Besirli
Journal:  Transl Vis Sci Technol       Date:  2019-09-27       Impact factor: 3.283

7.  Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.

Authors:  Sofia Theodoropoulou; Katarzyna Brodowska; Maki Kayama; Yuki Morizane; Joan W Miller; Evangelos S Gragoudas; Demetrios G Vavvas
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Efficient photodynamic therapy on human retinoblastoma cell lines.

Authors:  Jan Walther; Stanislas Schastak; Sladjana Dukic-Stefanovic; Peter Wiedemann; Jochen Neuhaus; Thomas Claudepierre
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Chebulagic acid from Terminalia chebula causes G1 arrest, inhibits NFκB and induces apoptosis in retinoblastoma cells.

Authors:  Naresh Kumar; D Gangappa; Geetika Gupta; Roy Karnati
Journal:  BMC Complement Altern Med       Date:  2014-08-29       Impact factor: 3.659

10.  Effects of metformin on retinoblastoma growth in vitro and in vivo.

Authors:  Katarzyna Brodowska; Sofia Theodoropoulou; Melissa Meyer Zu Hörste; Eleftherios I Paschalis; Kimio Takeuchi; Gordon Scott; David J Ramsey; Elizabeth Kiernan; Mien Hoang; Joanna Cichy; Joan W Miller; Evangelos S Gragoudas; Demetrios G Vavvas
Journal:  Int J Oncol       Date:  2014-09-11       Impact factor: 5.650
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.